ICTRP Search Portal

Please fill this short user satisfaction survey

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ChiCTR
Last refreshed on:	19 June 2017
Main ID:	ChiCTR-INR-17011642
Date of registration:	2017-06-12
Prospective Registration:	Yes
Primary sponsor:	Chinese food fermentation industry research institute
Public title:	Clinical research of fecal microbiota transplantation and probiotics regulating intestinal flora diversity on the systemic immune function in septic patients
Scientific title:	Clinical research of fecal microbiota transplantation and probiotics regulating intestinal flora diversity on the systemic immune function in septic patients
Date of first enrolment:	2017-07-01
Target sample size:	Fecal microbiota transplantation group :20;Probiotic group :20;Septic group :20;Non-septic group:20;
Recruitment status:	Pending
URL:	http://www.chictr.org.cn/showproj.aspx?proj=19823
Study type:	Interventional study
Study design:	Randomized parallel controlled trial
Phase:	New Treatment Measure Clinical Study

Countries of recruitment
China

Contacts

Name:	Xiaojun Yang
Address:	804 Shengli Street South, Xingqing District, Yinchuan, Ningxia Hui Autonomous Region, China
Telephone:	+86 13895101220
Email:	yxjicu@163.com
Affiliation:	General Hospital Of Ningxia Medical University

Name:	Xiaojun Yang
Address:	804 Shengli Street South, Xingqing District, Yinchuan, Ningxia Hui Autonomous Region, China
Telephone:	+86 13895101220
Email:	yxjicu@163.com
Affiliation:	General Hospital Of Ningxia Medical University

Key inclusion & exclusion criteria

Inclusion criteria: 1. Reach Sepisi3.0 diagnostic criteria;
2. Aged?18 years old.
Exclusion criteria: 1. Don't reach Sepisi3.0 diagnostic criteria;
2. Patients with perianal infection;
3. Patients with intestinal colostomy.

Age minimum: 18
Age maximum: 90
Gender: Both

Health Condition(s) or Problem(s) studied

Sepsis

Intervention(s)

Fecal microbiota transplantation group :Fecal microbiota transplantation;Probiotic group :Probiotics;Septic group :None ;Non-septic group:None ;

Primary Outcome(s)

gut microbiota composition;immunoglobulin;lymphocyte immune analysis;

Secondary Outcome(s)

nutritional indicators;28-day mortality;the incidence of MODS;

Secondary ID(s)

Source(s) of Monetary Support

Thirteen five national key scientific research projects

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.